Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Katherine Deane.

Newcastle AuthorsTitleYearFull text
Dr Kate Hackett
Dr Katherine Deane
Professor Julia Newton
Vincent Deary
Professor Tim Rapley
et al.
Mixed-Methods Study Identifying Key Intervention Targets to Improve Participation in Daily Living Activities in Primary Sjögren's Syndrome Patients2018
Dr Katie Hackett
Vincent Deary
Dr Katherine Deane
Professor Julia Newton
Dr Tim Rapley
et al.
“It isn’t pain pure and simple”: Experiences of pain and discomfort in primary Sjögren’s syndrome: A qualitative focus group study2017
Dr Katie Hackett
Dr Zoe Gotts
Dr John Ellis
Vincent Deary
Dr Tim Rapley
et al.
An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature2017
Dr Katie Hackett
Dr Dennis Lendrem
Dr Tim Rapley
Dr Katherine Deane
Vincent Deary
et al.
"Doing Every-Day Life" with Primary Sjogren's Syndrome: Factors Predicting Difficulties Performing Daily Activities and Taking on Life Roles2015
Dr Katie Hackett
Dr Katherine Deane
Vicki Strassheim
Vincent Deary
Dr Tim Rapley
et al.
A Systematic Review of Non-Pharmacological Interventions for Primary Sjögren's Syndrome.2015
Dr Katie Hackett
Dr Dennis Lendrem
Dr James Frith
Dr Tim Rapley
Vincent Deary
et al.
Cognitive Impairment in Primary Sjögren’s Syndrome2015
Dr Katie Hackett
Dr Dennis Lendrem
Dr James Frith
Dr Tim Rapley
Vincent Deary
et al.
Cognitive Symptoms are Common in Primary Sjogren's Syndrome and are Associated with Anxiety2015
Dr Katie Hackett
Dr Dennis Lendrem
Dr James Frith
Dr Tim Rapley
Vincent Deary
et al.
Cognitive symptoms are common in primary Sjögren's syndrome and are associated with anxiety2015
Dr Katie Hackett
Professor Julia Newton
Dr Katherine Deane
Dr Tim Rapley
Vincent Deary
et al.
Identifying participation barriers and key intervention targets for an autoimmune disease2015
Dr Katie Hackett
Dr Tim Rapley
Dr Niina Kolehmainen
Vincent Deary
Dr Katherine Deane
et al.
Identifying stakeholder informed priority targets for a non-pharmacological intervention package to improve functional capacity: a multi-centre mixed methods study2015
Dr Katie Hackett
Dr Katherine Deane
Dr Tim Rapley
Vincent Deary
Sarah Bowman
et al.
Identifying Targets for a Non-Pharmacological Therapy Intervention Package to Improve Participation in Primary Sjögren's Syndrome Patients: A Group Concept Mapping Study2015
Dr Katie Hackett
Dr Katherine Deane
Vincent Deary
Professor Julia Newton
Professor Tim Rapley
et al.
A Systematic Review of Non-Pharmacological Interventions for Primary Sjögren's Syndrome2014
Dr Katie Hackett
Professor Julia Newton
Dr Katherine Deane
Dr Tim Rapley
Vincent Deary
et al.
Developing a service user informed intervention to improve participation and ability to perform daily activities in primary Sjӧgren’s syndrome: a mixed methods study protocol2014
Dr Katie Hackett
Dr Katherine Deane
Vincent Deary
Dr Tim Rapley
Professor Julia Newton
et al.
Non-Pharmacological Interventions for Primary Sjogren's Syndrome: A Systematic Review of the Evidence2014
Dr Katie Hackett
Professor Julia Newton
Dr Tim Rapley
Dr Katherine Deane
Vincent Deary
et al.
Systematic reviews of occupational therapy interventions: summarizing research evidence and highlighting the gaps2014
Monique Lhussier
Dr Katherine Deane
Dr Mark Pennington
Dr Shelina Visram
Professor Martin White
et al.
An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health2011
Andrew Bryant
Dr Katherine Deane
Dr Alberto Lopes
Interventions for reducing anxiety in women undergoing colposcopy2011
Emeritus Professor Nick Miller
Dr Katherine Deane
Professor David Jones
Emma Noble
National survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: therapists’ practices2011
Dr Katherine Deane
Professor Martin Eccles
Public release of performance data in changing the behaviour of healthcare consumers, professionals or organisations2011
Emeritus Professor Nick Miller
Emma Noble
Professor David Jones
Dr Katherine Deane
Survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: patients’ and carers’ perspectives2011
Dr Katherine Deane
Randomised controlled trials: Part 1, design2006
Dr Katherine Deane
Randomised controlled trials: part 2, reporting2006
Dr Katherine Deane
Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease2004
Dr Katherine Deane
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease2004
Dr Katherine Deane
A Delphi survey of best practice occupational therapy for Parkinson's disease in the United Kingdom2003
Dr Katherine Deane
A survey of current occupational therapy practice for Parkinson's disease in the United Kingdom2003
Dr Katherine Deane
Amantadine for dyskinesia in Parkinson's disease2003
Dr Katherine Deane
Amantadine in Parkinson's disease2003
Dr Katherine Deane
Beta-blocker therapy for tremor in Parkinson's disease2003
Dr Katherine Deane
Systematic review of antidepressant therapies in Parkinson's disease2003
Dr Katherine Deane
The role of rehabilitation in Parkinson's disease: A review of the evidence2003
Dr Katherine Deane
Therapies for depression in Parkinson's disease2003
Dr Katherine Deane
Systematic review of paramedical therapies for Parkinson's disease2002
Dr Katherine Deane
Debra Jones
A comparison of physiotherapy techniques for patients with Parkinson's disease2001
Dr Katherine Deane
Cabergoline for levodopa-induced complications in Parkinson's disease2001
Dr Katherine Deane
Non-pharmacological therapies for dysphagia in Parkinson's disease2001
Dr Katherine Deane
Physiotherapy for patients with Parkinson's Disease: a comparison of techniques2001
Dr Katherine Deane
Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis2001
Dr Katherine Deane
Speech and language therapy for dysarthria in Parkinson's disease2001
Dr Katherine Deane
Ropinirole for levodopa-induced complications in Parkinson's disease2000